Etid klinik pou Depresyon nan Washington
21 etid pou Depresyon ap chèche patisipan nan sit nan Washington.
Vil nan Washington
Tèks ofisyèl etid la (Anglè)
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- Northwest Clinical Research Center, Bellevue
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Oct 1, 2026 · NCT07775300A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Core Clinical Research, Everett
- Seattle Neuropsychiatric Treatment Center, Seattle
Ap rekriteFaz 3
Laj 18 a 85 · Tout sèks · Mizajou Sep 25, 2026 · NCT06793397RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Seattle Neuropsychiatric Treatment Center, Seattle
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 15, 2026 · NCT07002034A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
- Seaport Investigator Site, Everett
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Sep 14, 2026 · NCT07065240PCORI Comparative Effectiveness Study-Esketamine (Spravato) vs. Ketamine-Equivalence Study
- Seattle NTC, Seattle
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT06713616A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
- Draig Clinical Site, Bellevue
- Draig Clinical Site, Seattle
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 2, 2026 · NCT07610473A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
- Draig Clinical Site, Bellevue
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Aug 26, 2026 · NCT07300969Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Aug 14, 2026 · NCT07226232A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Northwest Clinical Research Center, Bellevue
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Aug 6, 2026 · NCT07412756E-Mindfulness Approaches for Living After Breast Cancer
- Saint Joseph Medical Center Hematology and Oncology - Silverdale, Silverdale
Ap rekriteFaz 3
Laj 18 a 50 · Tout sèks · Mizajou Aug 4, 2026 · NCT06748222A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
- Core Clinical Research, Everett
Ap rekriteFaz 3
Laj 18 a 74 · Tout sèks · Mizajou Aug 3, 2026 · NCT06775379A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
- Core Clinical Research /ID# 226374, Everett
Ap rekriteFaz 3
Laj 10 a 17 · Tout sèks · Mizajou Jul 27, 2026 · NCT04777357Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Everett
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Jul 24, 2026 · NCT06966401CBT-I vs. MBTI for Traumatic Brain Injury (TBI)-Related Insomnia and Post-Traumatic Stress Symptoms
- Madigan Army Medical Center, Fort Lewis
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 13, 2026 · NCT05663034TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age
- Seattle Children's Hospital, Seattle
Ap rekriteEtid obsèvasyon
18 Months – 11 Years · Tout sèks · Mizajou Jul 6, 2026 · NCT07048574A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
- Center For Anxiety and Depression, Mercer Island
- Seattle Neuropsychiatric Treatment Center, Seattle
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 15, 2026 · NCT03887715A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- Seattle Neuropsychiatric Treatment Center, Bellevue
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou May 11, 2026 · NCT06524830Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus
- Seattle Children's Hospital, Seattle
Ap rekrite
Laj 12 a 22 · Tout sèks · Mizajou Oct 30, 2025 · NCT06232304Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Everett
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Oct 29, 2025 · NCT06786624A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
- Clinical Research Site, Everett
Ap rekriteFaz 4
Laj 18 a 65 · Tout sèks · Mizajou Jan 23, 2025 · NCT06223880Lay-Delivered Behavioral Activation in Senior Centers
- Enumclaw Senior Center, Enumclaw
- Casa Latina, Seattle
- Centro de la Raza, Seattle
- ak 1 plis
Ap rekrite
Laj 60 ak plis · Tout sèks · Mizajou Oct 15, 2024 · NCT04621877Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.